A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
Year of publication: |
2003
|
---|---|
Authors: | Maroun, Jean A. ; Asche, Carl ; Romeyer, Francoise ; Mukherjee, Jayanti ; Cripps, Christine ; Oza, Amit ; Skillings, Jamie R. ; Letarte, Jacques |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 21.2003, 14, p. 1039-1051
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Antineoplastics | Colorectal-cancer | Cost-minimisation | Fluorouracil | Folinic-acid | Pharmacoeconomics | Tegafur/uracil | Resource-use |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Monz, Brigitta U.M., (2003)
-
Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
Whyte, Sophie, (2012)
-
Cost Considerations in the Treatment of Colorectal Cancer
Jansman, Frank G.A., (2007)
- More ...
-
Torrance, George, (1999)
-
Seal, Brian, (2014)
-
Review of Models Used in Economic Analyses of New Oral Treatments for Type 2 Diabetes Mellitus
Asche, Carl, (2014)
- More ...